
Internal funding opportunity
FY27 UMGCCC Pilot Award Program
Applications are now open for pilot funding opportunities supporting innovative cancer research, clinical trainees, community engagement, grant resubmissions, and research infrastructure.
Fall Call for Proposals
Applications due September 30, 2026
- 5K Half Marathon (5KHM) Innovation Pilot Award — supports innovative, high-impact cancer research aligned with UMGCCC research priorities.
- Clinical Trainee Research Award — supports focused trainee projects leading to publications, grant submissions, or investigator-initiated trials.
- Community-Informed Research Award — integrates community engagement into cancer research addressing UMGCCC catchment-area priorities.
- Payline Program Award — provides additional support for favorably reviewed cancer-related grant applications that were not funded.
- Shared Resource & Research Infrastructure Development Award — supports the creation or enhancement of resources that broadly benefit UMGCCC investigators.
Rolling Opportunities
Applications accepted on an ongoing basis
- CRTEC NIH Support Award — supports trainees and junior investigators pursuing research likely to lead to NIH F-, K-, or R-series funding.
- Drug Discovery and Validation Pilot Award (DDVPA) – Sub-Category 1: Career Development in Target Discovery and Validation Pilot Award (CDPA) — supports early-stage lead identification and/or target validation projects through a partnership between the Center for Biomolecular Therapeutics (CBT) and UMGCCC.
- Drug Discovery and Validation Pilot Award (DDVPA) – Sub-Category 2: Advancing Drug Development — supports researchers in advancing their drug-development translational pipeline. Awards may be used to obtain services offered by UMB or UMGCCC consortium shared resource facilities, or a qualified contract research organization within the United States.
Coming Later in FY27
September 2026: Applications are expected to open for the UMGCCC CRTEC Department Trainee Travel Award, providing up to $500 toward presenting UMGCCC cancer research at a meeting.
March 2027: A second call is expected to open in mid-January, including the Translational Research Award and Multi-Year Collaborative Program Award. Applications will be due March 31, 2027.

NCI Requires UMGCCC Members Cite Cancer Center Resources in all Publications
- CRF: Publications resulting from research, training activities, pilot projects, and utilization of shared services supported by Cigarette Restitution Fund (CRF) award must contain the following acknowledgment:
“This (article, conference, publication, etc.) was supported by funds through the Maryland Department of Health's Cigarette Restitution Fund Program – CH-649-CRF.”
- P30 CCSG: Publications resulting from research, training activities, pilot projects, and utilization of shared services supported by Dr. Cullen’s P30 CCSG must contain the following acknowledgment (a PMCID will additionally need to be established):
“This (article, conference, publication, etc.) was supported by funds through the National Cancer Institute - Cancer Center Support Grant (CCSG) – P30CA134274.”
- Shared Resources: In addition to citing the P30 CCSG, publications resulting from utilization of shared resources must contain the following acknowledgment:
“The authors thank XXXX Shared Resource of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center for XXXX.”
- ACS-IRG: Present and Past Awardees, if you have received a pilot award through Dr. Webb’s (previously Dr. Martin) ACS-IRG Institutional Research Grant, please ensure you cite your publications appropriately.
Publications resulting from research or training activities supported by the American Cancer Society must contain the following acknowledgment:
"This (article, conference, publication, etc.) was supported by UMGCCC American Cancer Society Institutional Research Grant – IRG-18-160-16.”
Weekly Funding Opps
NIH
- NIH
- NCI
- NCI
- NCI
- NCILOI due 30 days before application due date
- NIHLOI Not Applicable
- NIHLOI Not Applicable
- NCILOI due 30 days before application due date
- NCIApplications are accepted by continuous receipt.
- NIH
- NIH
- NIH
- NCI
- NCI
- NCI
- NCI
NIH NOSI
- NIHExpiration Date: 5/1/25
- NIHFirst Available Due Date: January 16 2023
- NIHApplication Due: 09/06/26
- NCIApplication Due: 09/08/26
- NCIApplication Due: 10/10/26
- NCIApplication Due: 10/10/26
- NCIApplication Due: 11/17/26
- NIAIDApplication Due: 11/17/26
- NCIApplication Due: 01/08/27
- NCIApplication Due: 01/27/27
- NIHExpiration Date: 5/8/27
- NCIApplication Due: 05/10/27
- NIHApplication Due: 07/14/27
- NCINotice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer ResearchApplication Due: 07/31/27
- NCIApplication Due: 11/14/27
- NIHApplication Due: 09/08/28
- NCIApplication Due: 05/08/29
- NCIApplication Due: 05/08/29
- NCIApplication Due: 05/08/29
- NCIApplication Due: 05/08/29
Foundation
- American Cancer SocietyApplications submitted through June 1 will be reviewed in July. Applications submitted after June 1 will be reviewed in December. Grants start in September 2025 (July review) or 04/2026 (December)
- Breast Cancer AllianceLOI due: 03/31/2025
- Robert A. Winn Diversity in Clinical Trials Award Program
- OREF
- Colorectal Cancer Alliancerolling request for proposals
- Society for Immunology of Cancer
- Society for Immunology of Cancer
- Pew
- Alan B. Slifka Foundationsend a 1-2 page letter of intent (LOI) to sarcomaLOI@slifkafoundation.org.
- Melanoma Research Foundation
MDH
- Maryland Department of Healthsee each grant for specific deadline
Award
- Society for Immunotherapy of Cancer
Upcoming Events
- August 3, 2026
- August 4, 2026
- August 5, 2026
- August 6, 2026
- August 7, 2026
- September 3, 2026
News & Announcements
- Towson University Bridges to the Doctorate - provides students interested in earning a PhD in the biomedical sciences with the opportunity to earn a fully funded Master’s degree in Biology from Towson University (TU).
- Cancer Moonshot Scholars: Tapping a Deep Pool of Talent
- Raising the R01 Payline and Funding Other NCI Priorities
- Cancer Health Disparities "Think Tank" small groups
Contact: Dr. Laundette Jones at LPJones@som.umaryland.ed
- Slideshow on predatory journals: Predatory Journals
Contact Dr. Marey Shriver with any questions.
MPT Presents: 12th Grade From West Baltimore
Watch the latest in the documentary series “From West Baltimore” about our CURE Scholars program.

Research Programs
ET - Experimental Therapeutics
Maria Baer & Feyruz Rassool
co-program leaders
HRC - Hormone Related Cancers
Stuart Martin & Arif Hussain
co-program leaders
MSB - Molecular and Structural Biology
David Weber & France Carrier
co-program leaders
PS - Population Science
Joanne Dorgan & Cheryl Knott
co-program leaders
TII - Tumor Immunology and Immunotherapy
Xuefang Cao & Aaron Rapoport
co-program leaders

The Center for Advanced Research Training & Innovation (CARTI) is the “hub” for advanced biomedical research training and professional development opportunities for fellows and faculty at all career stages and open to all schools on campus with a focus on professional development for underrepresented minorities and women. CARTI provides classes, seminars, programs and resources to develop skills in effective grant writing, scientific communication, and scientific leadership skills necessary to succeed in an academic research institution.
Sign up for CARTI seminars and to receive their monthly newsletter.